NMPA Issued the Administrative Measures for Sampling Inspection of Medical Device Quality
To strengthen medical device administration and standardize the sampling inspection of medical device quality, NMPA has organized the revision of and released on March 13, 2020 the Administrative Measures for Sampling Inspection of Medical Device Quality. The Administrative Regulations on Quality Supervision and Sampling Inspection of Medical Devices (CFDA Department of Medical Device Supervision  No. 212) and the Work Procedures for National Medical Device Sampling Inspection (CFDA General Office  No. 213) issued by the former China Food and Drug Administration shall be repealed simultaneously.